Controlling blood lipids : part 2: when and how to use medication
Gespeichert in:
Deutscher übersetzter Titel: | Kontrolle der Blutlipide : Teil 2: Medikamentöse Therapie, wann und wie |
---|---|
Autor: | Mitchell, T.L.; Gibbons, L.W. |
Erschienen in: | The physician and sportsmedicine |
Veröffentlicht: | 26 (1998), 11, S. 56-65, Lit. |
Format: | Literatur (SPOLIT) |
Publikationstyp: | Zeitschriftenartikel |
Medienart: | Gedruckte Ressource Elektronische Ressource (online) |
Sprache: | Englisch |
ISSN: | 0091-3847, 2326-3660 |
DOI: | 10.3810/psm.1998.11.1202 |
Schlagworte: | |
Online Zugang: | |
Erfassungsnummer: | PU199901306466 |
Quelle: | BISp |
Abstract des Autors
Drug treatment for abnormal blood lipids includes bile acid sequestrants, fibric acid derivatives, statins, and niacin. Statins generally offer the best combination of safety and effectiveness. Hormone replacement therapy reduces the risk of coronary artery disease in postmenopausal women. The National Cholesterol Education Program offers clear guidelines as to what levels of low-density lipoprotein cholesterol (LDL-C) should trigger consideration of drug treatment, and the authors suggest what levels of high-density liporotein cholesterol should prompt treatment. Measurements of small dense LDL-C and lipoprotein(a) may also be helpful in decisions about drug treatment for selected patients. Verf.-Referat